NO762664L - - Google Patents

Info

Publication number
NO762664L
NO762664L NO762664A NO762664A NO762664L NO 762664 L NO762664 L NO 762664L NO 762664 A NO762664 A NO 762664A NO 762664 A NO762664 A NO 762664A NO 762664 L NO762664 L NO 762664L
Authority
NO
Norway
Application number
NO762664A
Other languages
Norwegian (no)
Other versions
NO143903C (no
NO143903B (no
Inventor
M Yasumoto
J Yamashita
I Yamawaki
N Unemi
K Kitazato
S Hashimoto
S Fujii
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50150936A external-priority patent/JPS6011032B2/ja
Priority claimed from JP15093775A external-priority patent/JPS6011033B2/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of NO762664L publication Critical patent/NO762664L/no
Publication of NO143903B publication Critical patent/NO143903B/no
Publication of NO143903C publication Critical patent/NO143903C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO762664A 1975-12-16 1976-07-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater NO143903C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50150936A JPS6011032B2 (ja) 1975-12-16 1975-12-16 2―置換―5―フルオルピリミジン―4―オン誘導体の製造法
JP15093775A JPS6011033B2 (ja) 1975-12-16 1975-12-16 5‐フルオルピリミジン―4―オン誘導体の製造法

Publications (3)

Publication Number Publication Date
NO762664L true NO762664L (cg-RX-API-DMAC7.html) 1977-06-17
NO143903B NO143903B (no) 1981-01-26
NO143903C NO143903C (no) 1981-05-06

Family

ID=26480366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762664A NO143903C (no) 1975-12-16 1976-07-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater

Country Status (12)

Country Link
US (1) US4080455A (cg-RX-API-DMAC7.html)
AU (1) AU505440B2 (cg-RX-API-DMAC7.html)
CA (1) CA1063606A (cg-RX-API-DMAC7.html)
CH (2) CH621544A5 (cg-RX-API-DMAC7.html)
DE (1) DE2633359C3 (cg-RX-API-DMAC7.html)
DK (1) DK137957B (cg-RX-API-DMAC7.html)
FI (1) FI61885C (cg-RX-API-DMAC7.html)
FR (1) FR2335228A1 (cg-RX-API-DMAC7.html)
GB (1) GB1501537A (cg-RX-API-DMAC7.html)
NL (1) NL162643C (cg-RX-API-DMAC7.html)
NO (1) NO143903C (cg-RX-API-DMAC7.html)
SE (1) SE439159B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68935B (cg-RX-API-DMAC7.html) * 1976-03-31 1982-03-29 Takeda Chemical Industries Ltd
JPS5446791A (en) * 1977-09-22 1979-04-12 Takeda Chem Ind Ltd Fluorouracil derivative
US4343940A (en) * 1979-02-13 1982-08-10 Mead Johnson & Company Anti-tumor quinazoline compounds
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
CN102532039B (zh) * 2010-09-29 2014-03-26 浙江工业大学 一种5-氟嘧啶-4(3h)-酮类化合物在制备抗肿瘤药物中的应用
CN101955465B (zh) * 2010-09-29 2012-07-04 浙江工业大学 一种5-氟嘧啶-4(3h)-酮类化合物及其制备方法和应用
CN102659689B (zh) * 2012-05-16 2014-12-17 浙江工业大学 4-取代-2-丁氧基-5-氟嘧啶类化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802005A (en) * 1957-08-06 S-eluorourace
US3784693A (en) * 1972-10-18 1974-01-08 Sandoz Ag 3-substituted phenyl-quinazoline-4(3h)-ones as sedative hypnotics
CH579057A5 (cg-RX-API-DMAC7.html) * 1973-09-07 1976-08-31 Hoffmann La Roche

Also Published As

Publication number Publication date
GB1501537A (en) 1978-02-15
FI762166A7 (cg-RX-API-DMAC7.html) 1977-06-17
DE2633359B2 (de) 1980-12-04
NL7608537A (nl) 1977-06-20
FR2335228B1 (cg-RX-API-DMAC7.html) 1978-11-17
NL162643C (nl) 1980-06-16
FI61885C (fi) 1982-10-11
SE7608306L (sv) 1977-06-17
DE2633359A1 (de) 1977-06-30
DE2633359C3 (de) 1981-12-17
DK137957C (cg-RX-API-DMAC7.html) 1978-11-06
US4080455A (en) 1978-03-21
DK137957B (da) 1978-06-12
NO143903C (no) 1981-05-06
FR2335228A1 (fr) 1977-07-15
CH625230A5 (cg-RX-API-DMAC7.html) 1981-09-15
CH621544A5 (cg-RX-API-DMAC7.html) 1981-02-13
NO143903B (no) 1981-01-26
AU505440B2 (en) 1979-11-22
NL162643B (nl) 1980-01-15
SE439159B (sv) 1985-06-03
DK346176A (cg-RX-API-DMAC7.html) 1977-06-17
FI61885B (fi) 1982-06-30
CA1063606A (en) 1979-10-02
AU1547576A (en) 1978-01-05

Similar Documents

Publication Publication Date Title
JPS546098Y2 (cg-RX-API-DMAC7.html)
JPS5284397U (cg-RX-API-DMAC7.html)
CH597683A5 (cg-RX-API-DMAC7.html)
CH587781A5 (cg-RX-API-DMAC7.html)
BG22713A1 (cg-RX-API-DMAC7.html)
BG22920A1 (cg-RX-API-DMAC7.html)
BG23097A1 (cg-RX-API-DMAC7.html)
BG23147A1 (cg-RX-API-DMAC7.html)
CH577919A5 (cg-RX-API-DMAC7.html)
CH582328A5 (cg-RX-API-DMAC7.html)
CH584450A5 (cg-RX-API-DMAC7.html)
CH598174A5 (cg-RX-API-DMAC7.html)
CH598081A5 (cg-RX-API-DMAC7.html)
BG21720A1 (cg-RX-API-DMAC7.html)
CH591249A5 (cg-RX-API-DMAC7.html)
CH592311A5 (cg-RX-API-DMAC7.html)
CH592735A5 (cg-RX-API-DMAC7.html)
CH593139A5 (cg-RX-API-DMAC7.html)
CH593434A5 (cg-RX-API-DMAC7.html)
CH595131A5 (cg-RX-API-DMAC7.html)
CH596337A5 (cg-RX-API-DMAC7.html)
CH596494A5 (cg-RX-API-DMAC7.html)
CH597079A5 (cg-RX-API-DMAC7.html)
CH597614A5 (cg-RX-API-DMAC7.html)
BG22122A1 (cg-RX-API-DMAC7.html)